[111In-DOTA]LTT-SS28

N/A

Report date: 2025/11/20 16:03:47

NME

Base Information

Drug Name[111In-DOTA]LTT-SS28

Drug Alias Name[111In-DOTA]LTT-SS28111In-DOTA-LTT-SS28

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor agonists

TargetsSomatostatin receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGreece

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNational Center For Scientific Research Demokritos

China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Scientific Research Demokritos

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A